Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 61151 - 61175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Pyrithione	Approved Investigational	CCNG1	900	downregulated	pyrithione zinc results in decreased expression of CCNG1 mRNA	5q34	A23728
Pyrithione	Approved Investigational	CDKN1A	1026	upregulated	pyrithione zinc results in increased expression of CDKN1A mRNA	6p21.2	A23728
Pyrithione	Approved Investigational	CHEK2	11200	upregulated	pyrithione zinc results in increased expression of CHEK2 mRNA	22q12.1	A23728
Pyrithione	Approved Investigational	CRYAB	1410	upregulated	pyrithione zinc results in increased expression of CRYAB mRNA	11q23.1	A23729
Pyrithione	Approved Investigational	CYP1A1	1543	upregulated	pyrithione zinc results in increased expression of CYP1A1 mRNA	15q24.1	A23728
Pyrithione	Approved Investigational	CYP7A1	1581	upregulated	pyrithione zinc results in increased expression of CYP7A1 mRNA	8q12.1	A23728
Pyrithione	Approved Investigational	DDB1	1642	upregulated	pyrithione zinc results in increased expression of DDB1 mRNA	11q12.2	A23728
Pyrithione	Approved Investigational	DDIT3	1649	upregulated	pyrithione zinc results in increased expression of DDIT3 mRNA	12q13.3	A23728
Pyrithione	Approved Investigational	DNAJA1	3301	upregulated	pyrithione zinc results in increased expression of DNAJA1 mRNA	9p21.1	A23729 A23728
Pyrithione	Approved Investigational	DNAJB4	11080	upregulated	pyrithione zinc results in increased expression of DNAJB4 mRNA	1p31.1	A23728
Pyrithione	Approved Investigational	EGR1	1958	upregulated	pyrithione zinc results in increased expression of EGR1 mRNA	5q31.2	A23729
Pyrithione	Approved Investigational	EPHX2	2053	upregulated	pyrithione zinc results in increased expression of EPHX2 mRNA	8p21.2-p21.1	A23728
Pyrithione	Approved Investigational	FMO1	2326	upregulated	pyrithione zinc results in increased expression of FMO1 mRNA	1q24.3	A23728
Pyrithione	Approved Investigational	FMO5	2330	downregulated	pyrithione zinc results in decreased expression of FMO5 mRNA	1q21.1	A23728
Pyrithione	Approved Investigational	FMO5	2330	upregulated	pyrithione zinc results in increased expression of FMO5 mRNA	1q21.1	A23728
Pyrithione	Approved Investigational	GADD45A	1647	upregulated	pyrithione zinc results in increased expression of GADD45A mRNA	1p31.3	A23728
Pyrithione	Approved Investigational	GDF15	9518	upregulated	pyrithione zinc results in increased expression of GDF15 mRNA	19p13.11	A23728
Pyrithione	Approved Investigational	GPX1	2876	upregulated	pyrithione zinc results in increased expression of GPX1 mRNA	3p21.31	A23728
Pyrithione	Approved Investigational	GSR	2936	upregulated	pyrithione zinc results in increased expression of GSR mRNA	8p12	A23728
Pyrithione	Approved Investigational	GSTM3	2947	upregulated	pyrithione zinc results in increased expression of GSTM3 mRNA	1p13.3	A23728
Pyrithione	Approved Investigational	HMOX1	3162	upregulated	pyrithione zinc results in increased expression of HMOX1 mRNA	22q12.3	A23729 A23728
Pyrithione	Approved Investigational	HSF1	3297	upregulated	pyrithione zinc results in increased expression of HSF1 mRNA	8q24.3	A23728
Pyrithione	Approved Investigational	HSP90AA1	3320	upregulated	pyrithione zinc results in increased expression of HSP90AA1 mRNA	14q32.31	A23728
Pyrithione	Approved Investigational	HSP90AB1	3326	upregulated	pyrithione zinc results in increased expression of HSP90AB1 mRNA	6p21.1	A23728
Pyrithione	Approved Investigational	HSPA1A	3303	upregulated	pyrithione zinc results in increased expression of HSPA1A mRNA	6p21.33	A23729 A23728

Displaying entries 61151 - 61175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability